Healthcare -
Biotechnology - NASDAQ - US
$ 9.235
-2.69 %
$ 2.84 B
Market Cap
-51.31
P/E
FOLD - OPERATING EXPENSES
Operating Expenses FOLD - Amicus Therapeutics, Inc.
450 M
LAST VALUE
-4.61%
2 YEAR CAGR
-0.46%
5 YEAR CAGR
20.48%
10 YEAR CAGR